Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers
about
Aldo-Keto Reductases 1B in Adrenal Cortex PhysiologyMethyl jasmonate: putative mechanisms of action on cancer cells cycle, metabolism, and apoptosisAn integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesionsA mechanically-induced colon cancer cell population shows increased metastatic potential.A gene signature to determine metastatic behavior in thymomas.Genetic variants in AKR1B10 associate with human eating behavior.Substrate Specificity, Inhibitor Selectivity and Structure-Function Relationships of Aldo-Keto Reductase 1B15: A Novel Human Retinaldehyde Reductase.Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases.Aldo-Keto Reductases 1B in Endocrinology and Metabolism.Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesotheliomaGlycative stress from advanced glycation end products (AGEs) and dicarbonyls: An emerging biological factor in cancer onset and progression.RBM5-AS1 Is Critical for Self-Renewal of Colon Cancer Stem-like Cells.Structural basis for the inhibition of AKR1B10 by caffeic acid phenethyl ester (CAPE).Editorial on research topic: aldo-keto reductases and role in human disease.Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity.Expression of AKR1B10 as an independent marker for poor prognosis in human oral squamous cell carcinoma.Aldo-Keto Reductase Regulation by the Nrf2 System: Implications for Stress Response, Chemotherapy Drug Resistance, and Carcinogenesis.
P2860
Q28078668-9DA997EC-9F62-495C-B747-07D2D9AAB497Q28658683-12C24798-DF34-4947-8AF0-9657A9F16E55Q33274526-0865F627-A25F-48C0-AC20-57CEC6814E07Q33276007-BCEF2E0F-9C51-4BE1-928C-7ABBC5F22AEEQ33600379-75516C2D-2029-4F73-B380-6A5F6C95A1D4Q33648303-89C9AE99-AC4D-4E38-BEE0-1C405E5222A9Q33812176-421AE98C-BFD5-4F4D-BFD4-C959A6172BB1Q34872271-F80EC75C-BBF9-4366-8B30-579D9E893C16Q35232887-EB987153-BB62-462B-9B87-A3C730539C48Q35723290-6CF44E11-9366-427F-AC41-8F8C6197D0B1Q35825211-A5D7B37E-414A-4223-8A70-0EC0EAE6CCA1Q36135903-1F362827-C67B-4F51-A0BD-82DE56D2A4C2Q37623620-8DA8F441-83D5-4545-9A70-07E873F16925Q38698770-5CB02F50-9EEE-46CA-A1E4-7EB9F119F58BQ38752182-0558E18D-AD5E-496D-A2DC-E5A11BB16B2DQ39270265-5D046802-A467-4D1C-910D-6C4FEFA3E1E1Q40870170-169C2571-2A62-481C-BE8F-96B8F091D7C6Q41943341-F8F7BAE5-EDF5-45B2-9060-F4E49A6BE87EQ48116483-A0F1599E-C1D2-4572-9346-F4EBF4C5EEF5Q48251191-69307A41-B55A-40EC-A563-8695CA726776
P2860
Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers
@en
type
label
Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers
@en
prefLabel
Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers
@en
P2093
P2860
P356
P1476
Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers
@en
P2093
Akira Hara
Midori Soda
Ossama El-Kabbani
Toshiyuki Matsunaga
Yasuhiro Wada
P2860
P356
10.3389/FPHAR.2012.00005
P50
P577
2012-01-31T00:00:00Z